BRPI0812875B8 - " método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste - Google Patents

" método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste

Info

Publication number
BRPI0812875B8
BRPI0812875B8 BRPI0812875A BRPI0812875A BRPI0812875B8 BR PI0812875 B8 BRPI0812875 B8 BR PI0812875B8 BR PI0812875 A BRPI0812875 A BR PI0812875A BR PI0812875 A BRPI0812875 A BR PI0812875A BR PI0812875 B8 BRPI0812875 B8 BR PI0812875B8
Authority
BR
Brazil
Prior art keywords
individual
risk
severe sepsis
test kit
vitro method
Prior art date
Application number
BRPI0812875A
Other languages
English (en)
Portuguese (pt)
Inventor
Björck Lars
Christensson Bertil
Herwald Heiko
Linder Adam
Äkesson Per
Original Assignee
Hansa Medical Ab
Hansa Biopharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38331957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0812875(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hansa Medical Ab, Hansa Biopharma AB filed Critical Hansa Medical Ab
Publication of BRPI0812875A2 publication Critical patent/BRPI0812875A2/pt
Publication of BRPI0812875B1 publication Critical patent/BRPI0812875B1/pt
Publication of BRPI0812875B8 publication Critical patent/BRPI0812875B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BRPI0812875A 2007-06-12 2008-06-12 " método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste BRPI0812875B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0711327.7A GB0711327D0 (en) 2007-06-12 2007-06-12 Diagnostic method
GB0711327.7 2007-06-12
PCT/EP2008/004743 WO2008151808A1 (en) 2007-06-12 2008-06-12 Diagnostic method

Publications (3)

Publication Number Publication Date
BRPI0812875A2 BRPI0812875A2 (pt) 2014-12-09
BRPI0812875B1 BRPI0812875B1 (pt) 2017-12-05
BRPI0812875B8 true BRPI0812875B8 (pt) 2022-07-12

Family

ID=38331957

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812875A BRPI0812875B8 (pt) 2007-06-12 2008-06-12 " método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste

Country Status (16)

Country Link
US (3) US8518648B2 (https=)
EP (1) EP2129391B1 (https=)
JP (1) JP5166522B2 (https=)
KR (1) KR101563997B1 (https=)
CN (2) CN101687023B (https=)
AT (1) ATE548050T1 (https=)
AU (1) AU2008261252B2 (https=)
BR (1) BRPI0812875B8 (https=)
CA (1) CA2690067C (https=)
DK (1) DK2129391T3 (https=)
ES (1) ES2380875T3 (https=)
GB (1) GB0711327D0 (https=)
PL (1) PL2129391T3 (https=)
PT (1) PT2129391E (https=)
SI (1) SI2129391T1 (https=)
WO (1) WO2008151808A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
US20100240049A1 (en) 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5488885B2 (ja) * 2009-10-28 2014-05-14 国立大学法人 東京大学 感染症の疾患マーカー
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
US20140037649A1 (en) * 2010-11-26 2014-02-06 Immunexpress Pty Ltd Diagnostic and/or screening agents and uses therefor
GB201102108D0 (en) * 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method
EP2756118A4 (en) * 2011-09-16 2015-09-16 Cepheid METHOD FOR DETECTING SEPSIS
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
US10761093B2 (en) 2014-10-09 2020-09-01 Texas Tech University System Microdevice for cell separation utilizing activation phenotype
CN109541235A (zh) * 2018-08-19 2019-03-29 重庆早柒天生物科技股份有限公司 肝素结合蛋白和降钙素原二联检测试剂盒及其制备方法
WO2020218121A1 (ja) 2019-04-24 2020-10-29 公益財団法人がん研究会 癌を検出する方法および検出試薬
CN111208305B (zh) * 2020-02-16 2023-04-25 重庆翼锋生物科技有限公司 Hbp和pct在败血症诊断试剂制备中的用途
CN111951963B (zh) 2020-07-30 2022-09-02 中翰盛泰生物技术股份有限公司 Hbp在covid-19患者的预后风险预警中的应用
WO2022229438A2 (en) * 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Il6 marker panels for early detection of sepsis
WO2022229421A2 (en) * 2021-04-30 2022-11-03 F. Hoffmann-La Roche Ag Strem1 marker panels for early detection of sepsis
WO2022229435A2 (en) * 2021-04-30 2022-11-03 Roche Diagnostics Gmbh Ngal marker panels for early detection of sepsis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627262A (en) 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5962241A (en) * 1989-07-28 1999-10-05 The University Of Arizona Monoclonal antibody detection of proteins on sperm related to fertility
US5314804A (en) * 1992-03-24 1994-05-24 Serim Research Corporation Test for Helicobacter pylori
RU2200573C2 (ru) 1994-04-21 2003-03-20 Леукотех А/С Связывающий гепарин белок для лечения сепсиса
US5976536A (en) 1995-08-09 1999-11-02 Emory University Neisseria mutants, lipooligosaccharides and immunogenic compositions
US5778895A (en) 1997-01-29 1998-07-14 Uab Research Foundation Method of discriminating bacterial from aseptic meningitis
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
AU2003220034A1 (en) 2002-03-08 2003-09-22 Heloise, Anne, Pereira, Ph. D. An early detection marker for chronic inflammatory associated diseases
US7655480B2 (en) 2002-03-08 2010-02-02 The Board Of Regents Of The University Of Oklahoma Method for predicting sepsis or an acute infectious inflammatory response
WO2004016653A2 (en) 2002-08-15 2004-02-26 Leukotech A/S Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase
CA2516836A1 (en) * 2003-02-24 2004-09-10 Gtc Biotherapeutics, Inc. Methods of tangential flow filtration and an apparatus therefore
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
EP1638530A2 (en) * 2003-06-20 2006-03-29 Royer Biomedical, INC. Drug polymer complexes
WO2005028512A1 (en) * 2003-09-19 2005-03-31 Leukotech A/S Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp)
US20050196817A1 (en) 2004-01-20 2005-09-08 Molecular Staging Inc. Biomarkers for sepsis
CA2605143A1 (en) * 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
WO2007041623A2 (en) 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
FR2894675B1 (fr) 2005-12-14 2008-06-27 Assist Publ Hopitaux De Paris Distinction des meningites bacteriennes et virales
GB0711327D0 (en) 2007-06-12 2007-07-25 Hansa Medical Ab Diagnostic method
GB201016161D0 (en) 2010-09-24 2010-11-10 Hansa Medical Ab Diagnostic method
GB201102108D0 (en) 2011-02-07 2011-03-23 Hansa Medical Ab Diagnostic method

Also Published As

Publication number Publication date
DK2129391T3 (da) 2012-06-11
US20130252347A1 (en) 2013-09-26
US8518648B2 (en) 2013-08-27
JP2010529468A (ja) 2010-08-26
BRPI0812875A2 (pt) 2014-12-09
CN103543271A (zh) 2014-01-29
US9784741B2 (en) 2017-10-10
CN101687023B (zh) 2016-04-20
ES2380875T3 (es) 2012-05-21
WO2008151808A1 (en) 2008-12-18
US20100305185A1 (en) 2010-12-02
CA2690067A1 (en) 2008-12-18
BRPI0812875B1 (pt) 2017-12-05
PT2129391E (pt) 2012-06-06
KR20100021578A (ko) 2010-02-25
AU2008261252A1 (en) 2008-12-18
ATE548050T1 (de) 2012-03-15
CA2690067C (en) 2023-09-19
CN101687023A (zh) 2010-03-31
US20140187503A1 (en) 2014-07-03
GB0711327D0 (en) 2007-07-25
SI2129391T1 (sl) 2012-07-31
PL2129391T3 (pl) 2012-09-28
KR101563997B1 (ko) 2015-10-28
EP2129391A1 (en) 2009-12-09
AU2008261252B2 (en) 2013-03-14
EP2129391B1 (en) 2012-03-07
JP5166522B2 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
BRPI0812875B8 (pt) " método in vitro para indentificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, e, kit de teste
GB2477877A (en) Colorimetric test for brake system corrosion
BR112015004881A2 (pt) método para diagnosticar o estado da doença periodontal e kit para diagnosticar o estado da doença periodontal
EP2212700B8 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2007143211A3 (en) Methods for identifying agents and their use for the prevention of restenosis
BR112012031166A2 (pt) compensação baseada eminclinação incluindo sinais de saída secundários
Loria et al. Sex‐specific alterations in NOS regulation of vascular function in aorta and mesenteric arteries from spontaneously hypertensive rats compared to Wistar Kyoto rats
DiRocco et al. A role for calmodulin-stimulated adenylyl cyclases in cocaine sensitization
WO2005031005A3 (en) Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
ATE420374T1 (de) Automatisches testsystem mit leicht modifizierter software
BRPI0807601B8 (pt) método para identificação de um paciente que esteja em risco com relação ao desenvolvimento de um distúrbio na tireoide e uso de um agente depletivo de linfócitos
BRPI0607912A2 (pt) ensaio para determinar a presença, ausência ou saúde de uma célula, analito, ácido nucléico ou microorganismo em uma amostra, sonda, métodos para selecionar um analito que se ligue a um composto, para determinar se um ácido nucléico de interesse interage com uma proteína de interesse em uma célula ou uma amostra invitro, e para determinar a presença ou ausência de um ou mais compostos alvo em uma amostra, kit para manchar células, analitos, ácidos nucléicos ou microorganismos em uma amostra, e, composto"
AR058959A1 (es) Metodos para modular receptores de la superficie celular para prevenir o reducir la inmflamacion
BR112022003869A2 (pt) Método não invasivo para quantificar função renal e declínio funcional
MX2021009281A (es) Metodos de deteccion de legionella.
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer
Pacheco et al. Optimization of a filter‐lysis protocol to purify rat testicular homogenates for automated spermatid counting
ES2571929T3 (es) Procedimiento para determinar la cantidad de CD36 circulante
CL2011000363A1 (es) Metodo para identificar predisposicion a hepatotoxicidad mediante el alelo hla dqa1*0102, drb1*1501, dqb1*0602, drb5*0101; uso de sonda que detecta el alelo para determinar la susceptibilidad a desarrollar hepatotoxicidad luego de administrar lumiracobix; uso de lumiracobix para tratamiento de trastornos mediados por cox-2.
DE502005011186D1 (de) Stabiles, chromogenes Testreagenz und dessen Verwendung in gerinnungsdiagnostischen Tests
AR062117A1 (es) Composicion y metodo para el tratamiento de tumores
Esmi et al. The study of phonetic coherence in Surahs Havamim, by measuring the homogeneity of the saj types
Todorova et al. Quantitative evaluation of AMACR in glioblastoma
RU2006142106A (ru) Способ оценки фертильных свойств эякулята

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B25D Requested change of name of applicant approved